118 HR 71 IH: Medical Innovation Acceleration Act of 2023 U.S. House of Representatives 2023-01-09 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I118th CONGRESS1st SessionH. R. 71IN THE HOUSE OF REPRESENTATIVESJanuary 9, 2023Mr. Biggs introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.

1.

Short title

This Act may be cited as the Medical Innovation Acceleration Act of 2023.

2.

Exempting non-invasive diagnostic devices from regulation as devices

Section 201(h) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(h)) is amended— (1)by striking section 520(o) and inserting the following: section 520(o) or any non-invasive diagnostic device; and (2)by adding at the end the following: For purposes of the preceding sentence, the term non-invasive means, with respect to a diagnostic device, that the device does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation..